Infant cold medicines pulled for overdose risk
Nonprescription products for children under age 2
MSNBC News Services
Updated: 5:12 a.m. PT Oct 11, 2007
CHICAGO - Johnson & Johnson, Wyeth and other makers of infants’ nonprescription cough and cold products are recalling certain medicines in the United States because of the danger of overdose, the Consumer Healthcare Products Association said on Thursday.
Novartis and Prestige Brands Holdings are recalling their oral infant cough and cold medicines, as well, because data show that when the medicines are misused, it can lead to overdose, especially in children under the age of 2 years.
CVS Caremark Corp. is also removing the nonprescription products from its drugstores following the voluntary recalls.
The pharmacy chain said it will immediately remove all products subject to the recall as well as any store-brand equivalents. Customers who bought the products at a CVS store may return them for a full refund, the company said.
A spokeswoman for Consumer Heathcare, a trade association representing the makers of over-the-counter medicines, said overdoses have led to death and serious injury in rare instances.
In a statement, J&J's McNeil-PPC unit cited "rare instances of misuse", which could lead to overdoses.
The products being recalled include: infants' Tylenol Drops Plus Cold; Concentrated Infants' Tylenol Drops Plus Cold & Cough; Pediacare Infant Drops Decongestant; Pediacare Infant Drops Decongestant & Cough; Pediacare Infant Dropper Decongestant; Pediacare Infant Dropper Long-Acting Cough; and Pediacare Infant Dropper Decongestant & Cough (PE) products.
Cough and cold products for children age two and over and single-ingredient pain reliever and fever reducers expressly labeled for infants are not included in the recall.
The recall comes two months after the Food and Drug Administration issued a public health advisory warning parents not to give cough and cold medications to children under 2 years of age without a doctor's direction. The FDA's Nonprescription Drugs Advisory Committee will meet Oct. 18-19 to discuss the use of cough and cold drugs by children.
Safety experts for the U.S. Food and Drug Administration have urged the agency to consider a ban on these medicines for children under the age of 6 years.
Many experts say there is little evidence that these medicines are effective in such young children and are calling for mandatory warning labels that say the medicines should not be used in children under 2 years of age.
Questions about the products should be directed to McNeil's Consumer Relationship Center at 1-877-895-3665 (English) or 1-888-466-8746 (Spanish).
The Associated Press and Reuters contributed to this report
URL:
Infant cold medicines pulled for overdose risk - Kids & Parenting - MSNBC.com